Expertise in
1
conditions

Dr. Kevin Cannon

Internal Medicine
Wha Medical Clinic PLLC
1202 Medical Center Dr, 
Wilmington, NC 
Offers Telehealth
Expertise in
1
conditions
Wha Medical Clinic PLLC
1202 Medical Center Dr, 
Wilmington, NC 

Overview

Kevin Cannon is an Internal Medicine provider in Wilmington, North Carolina. Dr. Cannon is highly rated in 1 condition, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Liver Failure, Endoscopy, and Gastrostomy.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Internal Medicine

Licenses

Hospitalist in NC

Hospital Affiliations

Novant Health New Hanover Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Wha Medical Clinic PLLC
1202 Medical Center Dr, Wilmington, NC 28401
Other Locations
Office
1907 Tradd Ct, Wilmington, NC 28401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85
A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85
Enrollment Status: Completed
Publish Date: May 18, 2025
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Phase 1/2, Randomized, Observer-Blind, Dose-Finding, Controlled, Parallel-Group, Two-Stage Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Adults Aged 18 to 64 Years
A Phase 1/2, Randomized, Observer-Blind, Dose-Finding, Controlled, Parallel-Group, Two-Stage Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Adults Aged 18 to 64 Years
Enrollment Status: Completed
Publish Date: April 18, 2024
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
Phase I/II, Observer-blind, Safety, Reactogenicity and Immunogenicity Study of GSK Biologicals' Respiratory Syncytial Virus (RSV) Vaccine GSK3844766A in Subjects Aged 18-40 or 60-80 Years
Phase I/II, Observer-blind, Safety, Reactogenicity and Immunogenicity Study of GSK Biologicals' Respiratory Syncytial Virus (RSV) Vaccine GSK3844766A in Subjects Aged 18-40 or 60-80 Years
Enrollment Status: Completed
Publish Date: August 05, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
View 5 Less Clinical Trials

2 Total Publications

Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.
Journal: The New England journal of medicine
Published: November 19, 2025
Similar Doctors
Expertise in
20
conditions
Dr. Brian Donner
Internal Medicine
Expertise in
20
conditions
Dr. Brian Donner
Internal Medicine

Private Diagnostic Clinic PLLC

1302 Medical Center Dr, 
Wilmington, NC 
 (0.1 miles away)
910-343-9800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Brian Donner is an Internal Medicine provider in Wilmington, North Carolina. Dr. Donner is highly rated in 20 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Nephrosclerosis, and Renovascular Hypertension.

Expertise in
80
conditions
Dr. Mary Rudyk
Internal Medicine
Expertise in
80
conditions
Dr. Mary Rudyk
Internal Medicine

Senior Health Associates P.A.

1709 S 16th St Ste A, 
Wilmington, NC 
 (5.2 miles away)
910-452-8633
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mary Rudyk is a primary care provider, practicing in Internal Medicine in Wilmington, North Carolina. Dr. Rudyk is highly rated in 80 conditions, according to our data. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Endoscopy, and Gastrostomy.

Expertise in
20
conditions
Dr. Robert Moore
Internal Medicine
Expertise in
20
conditions
Dr. Robert Moore
Internal Medicine

Private Diagnostic Clinic PLLC

1302 Medical Center Dr, 
Wilmington, NC 
 (0.1 miles away)
910-343-9800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Moore is an Internal Medicine provider in Wilmington, North Carolina. Dr. Moore is highly rated in 20 conditions, according to our data. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.

Frequently Asked Questions about Dr. Kevin Cannon

How do I make an appointment with Dr. Kevin Cannon?

You can book an appointment with Dr. Kevin Cannon by calling their office at 910-341-3300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kevin Cannon a top-rated expert for Endoscopy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kevin Cannon is classified as an Advanced expert for Endoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kevin Cannon specialize in?

While Dr. Kevin Cannon is a Internal Medicine, they have specific expertise in Endoscopy, Gastrostomy, and Colonoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Kevin Cannon participate in research or clinical trials?

Yes. Dr. Kevin Cannon has published 2 articles and abstracts on conditions like Endoscopy. You can view a list of Dr. Kevin Cannon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kevin Cannon accept my insurance?

Dr. Kevin Cannon accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 910-341-3300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cannon's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile